| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 22, 2024 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 55 | $400.00 | $22,000.00 | - | -0.1% | -24.8% | |
| May 20, 2024 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 4,020 | $400.19 | $1,608,763.80 | -0.6% | -1.3% | -22.8% | |
| May 17, 2024 | PSNL Personalis, Inc. | Moore Stephen Michael52 | SVP And Chief Legal Officer | Sell | 1,731 | $1.38 | $2,388.78 | -2.4% | +262.1% | +253.6% | |
| May 17, 2024 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 163,997 | $1.29 | $211,195.34 | - | +19.7% | +0.8% | |
| May 17, 2024 | PSNL Personalis, Inc. | Chen Richard70 | Chief Medical Officer And EVP | Sell | 940 | $1.38 | $1,297.20 | -0.7% | +262.1% | +253.6% | |
| May 17, 2024 | PSNL Personalis, Inc. | Tachibana Aaron68 | CFO And COO | Sell | 1,333 | $1.38 | $1,839.54 | -0.7% | +262.1% | +253.6% | |
| May 16, 2024 | MTD Mettler Toledo International Inc/ | Vadala Shawn68 | Chief Financial Officer | Sell | 300 | $1,528.43 | $458,527.76 | -3.0% | -8.4% | -24.4% | |
| May 16, 2024 | XGN Exagen Inc. | Aballi John64 | President And CEO | Buy | 40,401 | $1.92 | $77,569.92 | New | +51.3% | +218.0% | |
| May 16, 2024 | DHR Danaher Corp /de/ | Blair Rainer63 | President &CEO | Sell | 9,005 | $265.00 | $2,386,325.00 | -7.8% | +1.2% | -26.0% | |
| May 16, 2024 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 39,342 | $404.76 | $15,924,222.06 | -2.8% | -2.1% | -22.3% | |
| May 15, 2024 | CRL Charles River Laboratories International, Inc. | Massaro George66 | Director | Sell | 332 | $235.62 | $78,225.37 | -1.8% | -12.5% | -40.3% | |
| May 15, 2024 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 6,779 | $107.08 | $725,911.15 | -1.5% | +10.9% | +39.2% | |
| May 15, 2024 | WAT Waters Corp /de/ | Kuebler Christopher A58 | Director | Sell | 4,000 | $361.64 | $1,446,560.00 | -21.4% | -6.3% | -2.8% | |
| May 15, 2024 | MTD Mettler Toledo International Inc/ | Keller Gerry64 | Head Of Process Analytics | Sell | 310 | $1,511.56 | $468,583.60 | -98.1% | -6.6% | -24.8% | |
| May 15, 2024 | NEO Neogenomics Inc | Olivo Alicia C69 | General Counsel | Sell | 1,049 | $15.74 | $16,511.26 | -2.3% | +8.9% | -48.2% | |
| May 15, 2024 | MYGN Myriad Genetics Inc | Diaz Paul J74 | President And CEO | Sell | 227,844 | $25.14 | $5,728,763.31 | -6.2% | +14.3% | -83.3% | |
| May 14, 2024 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 6,336 | $24.27 | $153,753.14 | -1.2% | +11.9% | -31.7% | |
| May 14, 2024 | TMO Thermo Fisher Scientific Inc. | Lagarde Michel62 | Executive Vice President &COO | Sell | 20,000 | $590.05 | $11,801,000.00 | -52.4% | +0.7% | -31.7% | |
| May 14, 2024 | DHR Danaher Corp /de/ | Blair Rainer63 | President &CEO | Sell | 19,085 | $255.00 | $4,866,675.00 | -14.1% | +3.1% | -27.6% | |
| May 14, 2024 | MTD Mettler Toledo International Inc/ | Vadala Shawn68 | Chief Financial Officer | Sell | 2,030 | $1,475.20 | $2,994,661.00 | -8.7% | -7.9% | -25.3% | |
| May 13, 2024 | MTD Mettler Toledo International Inc/ | Salice Thomas P65 | Director | Sell | 1,268 | $1,490.18 | $1,889,550.63 | -43.7% | -5.7% | -19.5% | |
| May 13, 2024 | WGS Genedx Holdings Corp. | Casdin Capital, LLC97 | Director, 10% Owner | Buy | 50,000 | $23.31 | $1,165,295.00 | +1.8% | +43.2% | +160.6% | |
| May 13, 2024 | TMO Thermo Fisher Scientific Inc. | Williamson Stephen68 | Sr. VP And CFO | Sell | 21,925 | $591.27 | $12,963,594.75 | -37.5% | +1.4% | -27.4% | |
| May 13, 2024 | MTD Mettler Toledo International Inc/ | Magloth Christian66 | Head Of Human Resources | Sell | 1,100 | $1,470.97 | $1,618,067.00 | -60.0% | -5.7% | -19.5% | |
| May 13, 2024 | MYGN Myriad Genetics Inc | Newcomer Lee Nisley | Director | Sell | 6,200 | $25.30 | $156,860.00 | -8.5% | +12.1% | -83.5% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.